REVENUE (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue

The following table presents the Company’s revenues disaggregated by revenue source:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	2023		2022		2023		2022
Screening
Medicare Parts B & C	$	173,624	$	140,366	$	521,370	$	389,373
Commercial	253,401		188,923		732,182		531,789
Other	44,988		31,470		124,443		100,013
Total Screening	472,013		360,759		1,377,995		1,021,175
Precision Oncology
Medicare Parts B & C	$	46,383	$	47,038	$	141,352	$	152,224
Commercial	44,430		42,660		135,574		134,658
International	38,599		31,533		111,453		89,536
Other	26,913		30,212		80,552		81,640
Total Precision Oncology	156,325		151,443		468,931		458,058
COVID-19 Testing	$	—	$	10,871	$	5,955	$	52,051
Total	$	628,338	$	523,073	$	1,852,881	$	1,531,284